Email: dvtustudies@duke.edu | Telephone: 919-971-5649
Active Clinical Trials
Dr. Walter is leading a study to evaluate the safety, tolerability, and immunogenicity of a combined modified RNA vaccine candidate against COVID-19 and influenza in healthy adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06178991.
Dr. Wolfe is leading a study to evaluate the immunogenicity and safety of mRNA-1345, an mRNA vaccine targeting respiratory syncytial virus in high-risk adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06067230.
Dr. McKellar is leading a study to evaluate the safety and immunogenicity of the ChAdOx1.HIVconsv62 - MVA.tHIVconsv4 (C62-M4) or, ChAdOx1.tHIVconsv1+C62 - MVA.tHIVconsv3+M4 (C1C62-M3m4) PRIME-BOOST REGIMENS in persons with HIV-1 suppressed on antiretroviral therapy. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT05604209.
Dr. Smith is leading a study to assess the safety of simultaneous vaccination with mRNA COVID-19 vaccine and other vaccines in young children aged 6 Months to <5 years. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06038617.
Dr. Walter is leading a Phase 1 study to assess the safety and immunogenicity of a single dose of an investigational mRNA influenza vaccine in healthy adults age 18 to 49 years. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT05755620.
Dr. Walter is leading a study to investigate the safety, tolerability and immunogenicity of variant-adapted BNT162b2 RNA-based vaccine candidates in healthy children. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT05543616.
Dr. Wolfe is leading a vaccine study comparing high dose flu vaccine to standard dose flu vaccine in individuals following solid organ transplant (SOT). DVTU is a subcontractor to Vanderbilt for the study. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT04613206.
Drs. Woods and Walter are leading a registry study to enroll healthy persons for future participation in influenza, SARS-CoV-2, and other respiratory pathogen vaccination studies and influenza challenge studies.